Shivani named one of top 20 women leaders in biopharma R&D  
Endpoints | Dec 2021

Shivani receives V Foundation Bob Bast Translational Research Grant for proposal with one of the highest ratings by the Scientific Advisory Committee
V Foundation | Nov 2021

Shivani receives CCSG New Investigator Award
Hutch News | July 2021

Shivani receives Lung Cancer Discovery Award from the American Lung Association
American Lung Association | July 2021

Researchers in biotech, academia and Big Pharma are offering puzzle pieces to crack CAR-T for solid tumors. Will they ever snap together?
Endpoints | May 2021

Science Snacks: Dr. Shivani Srivastava on CAR T-cell therapy
Fred Hutch | April 2021

Shivani receives 10X Visium Technology Exploratory Award 
Hutch News | April 2021

Spotlight on Shivani Srivastava, Improving Cancer Immunotherapies
Hutch News | March 2021

Science Spotlight, Remodeling the tumor microenvironment for improved CAR T-cell therapy
Hutch News | February 2021

Dr. Shivani Srivastava joins Human Biology Division, Immunotherapy IRC
Hutch News | January 2021

Dr. Shivani Srivastava (’04) honored with the Distinguished Alumni Award for 2019
The Overlake School | January 2020

Logic-gated CAR-T cells safely target distant tumor cells
Hutch News | May 2019

Tinkering with T cells
Hutch News | May 2018